|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 760.70 BDT | -0.48% |
|
+0.89% | +7.44% |
| Market Cap | 1.82B 14.74M 12.9M 11.89M 10.99M 20.85M 1.41B 21.2M 142M 55.81M 693M 55.36M 54.15M 2.38B | P/E 2024 |
189x | P/E 2025 | 369x |
|---|---|---|---|---|---|
| Enterprise Value | 2.32B 18.85M 16.49M 15.21M 14.05M 26.66M 1.8B 27.11M 182M 71.37M 886M 70.79M 69.25M 3.05B | EV / Sales 2024 |
10.4x | EV / Sales 2025 | 10.7x |
| Free-Float |
22.75% | Yield 2024 |
0.13% | Yield 2025 | 0.12% |
| 1 day | -0.48% | ||
| 1 week | +0.89% | ||
| Current month | +0.56% | ||
| 1 month | -2.29% | ||
| 3 months | +0.71% | ||
| 6 months | +6.35% | ||
| Current year | +7.44% |
| 1 week | 751.1 |  | 780 |
| 1 month | 750 | | 782 |
| Current year | 689 | | 821 |
| 1 year | 681 | | 929 |
| 3 years | 511 | | 1,302.3 |
| 5 years | 375.3 | | 1,302.3 |
| 10 years | 285.6 | | 1,302.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Director of Finance/CFO | - | - | |
| Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | - | |
| Director/Board Member | - | - | |
Nurjehan Hudda
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.48% | +0.89% | -5.11% | +45.78% | 14.81M | |
| -0.17% | +3.45% | +15.94% | +86.88% | 48.73B | |
| +1.04% | -3.54% | +67.29% | +114.44% | 35.82B | |
| -0.13% | -1.14% | -3.51% | +41.03% | 12.2B | |
| -0.71% | +4.64% | +17.61% | +97.65% | 12.11B | |
| +0.86% | +1.75% | +34.02% | +123.93% | 9.11B | |
| -0.86% | +1.08% | +53.57% | -3.92% | 7.09B | |
| +0.75% | -0.82% | +17.49% | +44.79% | 7B | |
| +0.69% | +3.96% | +25.52% | +231.22% | 6.7B | |
| +5.45% | +1.89% | -18.02% | +13.55% | 5.78B | |
| Average | +0.64% | +0.36% | +20.48% | +79.53% | 14.46B | |
| Weighted average by Cap. | +0.43% | +0.51% | +29.31% | +90.34% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 219M 1.78M 1.56M 1.44M 1.33M 2.52M 170M 2.56M 17.17M 6.74M 83.67M 6.69M 6.54M 288M | 231M 1.87M 1.64M 1.51M 1.4M 2.65M 179M 2.69M 18.05M 7.09M 87.96M 7.03M 6.88M 302M |
| Net income | 9.68M 78.63K 68.78K 63.44K 58.59K 111K 7.5M 113K 758K 298K 3.69M 295K 289K 12.7M | 5.31M 43.11K 37.71K 34.78K 32.13K 60.96K 4.11M 61.98K 416K 163K 2.03M 162K 158K 6.96M |
| Net Debt | 445M 3.61M 3.16M 2.91M 2.69M 5.11M 344M 5.19M 34.81M 13.67M 170M 13.56M 13.26M 583M | 506M 4.11M 3.6M 3.32M 3.06M 5.81M 392M 5.91M 39.63M 15.56M 193M 15.44M 15.1M 664M |
Employees
474
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/07/26 | BDT 760.70 | -0.48% | 1,544 |
| 08/07/26 | BDT 764.40 | -1.76% | 1,607 |
| 07/07/26 | BDT 778.10 | +1.83% | 2,009 |
| 06/07/26 | BDT 764.10 | +1.33% | 1,004 |
| 05/07/26 | BDT 754.10 | +0.01% | 2,093 |
- Stock Market
- Stocks
- AMBEEPHA Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
